β¨ Medicines Distribution Consent
16 DECEMBER 2010 NEW ZEALAND GAZETTE, No. 173 4257
Product: Arrow-Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 84.86mg equivalent to venlafaxine 75mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Liconsa SA, Guadalajara, Spain
Product: Arrow-Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 169.72mg equivalent to venlafaxine 150mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Liconsa SA, Guadalajara, Spain
Product: Arrow-Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 254.58mg equivalent to venlafaxine 225mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Liconsa SA, Guadalajara, Spain
Product: Fendine Antihistamine
Active Ingredient: Fexofenadine hydrochloride 60mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Cipla Limited, Raigad, India
Product: Fendine Antihistamine
Active Ingredient: Fexofenadine hydrochloride 120mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Cipla Limited, Raigad, India
Dated this 3rd day of December 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go9543
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Actrapid
Active Ingredient: Neutral insulin, human, pyr 100IU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Product: Actrapid Flexpen
Active Ingredient: Neutral insulin, human, pyr 100IU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk Production SAS, Chartres Cedex, France
Novo Nordisk Producao Farmaceutica do Brasil Limiteda, Montes Claros, Brazil
Product: Actrapid Innolet
Active Ingredient: Neutral insulin, human, pyr 100IU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Novo Nordisk Pharmaceuticals Limited
Manufacturers: Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk Producao Farmaceutica do Brasil Limiteda, Montes Claros, Brazil
Product: Actrapid Penfill
Active Ingredient: Neutral insulin, human, pyr 100IU/mL
Dosage Form: Solution for injection
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare3 December 2010
Medicines, Distribution, Consent, Medicines Act 1981, Arrow-Venlafaxine XR, Fendine Antihistamine
- JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare3 December 2010
Medicines, Distribution, Consent, Medicines Act 1981, Actrapid, Novo Nordisk
- JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health
NZ Gazette 2010, No 173